Rebulla P, Modell B
Centro Trasfusionale e de Immunologia dei Trapianti, Ospedale Policlinico, Milano, Italy.
Lancet. 1991 Feb 2;337(8736):277-80. doi: 10.1016/0140-6736(91)90881-o.
Analysis of data available in 1985 on 3468 Italian and Greek patients registered in Cooleycare, an international cooperative programme of quality assessment of treatment delivery in thalassaemia, gave the following picture of treatment requirements and effects. The proportion of patients undergoing splenectomy has progressively decreased, and age at splenectomy has increased with time over the past 20 years. Age at first transfusion exceeds 4 years in a small but important group of patients, which indicates that a milder form of thalassaemia exists in this group. Children receiving modern treatment remain of near-normal stature until age 11 but later tend to be stunted. The mean blood requirement is 35% higher in non-splenectomised than in splenectomised patients. Differences in transfusion interval of 2 to 4 weeks have no measurable effect on blood requirement. Mean blood requirement rises gradually with mean haemoglobin concentration, possibly in a non-linear fashion. The prevalence of red cell alloimmunisation rises with delay in start on transfusion. Transfusion reactions were reported in 1% of transfusions (90% of which were leucocyte-depleted), from 17% of patients.
对1985年在国际地中海贫血治疗质量评估合作项目Cooleycare中登记的3468名意大利和希腊患者的现有数据进行分析,得出了以下关于治疗需求和效果的情况。在过去20年中,接受脾切除术的患者比例逐渐下降,且脾切除的年龄随时间增加。一小部分但很重要的患者首次输血年龄超过4岁,这表明该组存在病情较轻的地中海贫血形式。接受现代治疗的儿童在11岁前身高接近正常,但之后往往发育迟缓。未进行脾切除的患者平均血液需求量比进行脾切除的患者高35%。输血间隔2至4周的差异对血液需求量没有可测量的影响。平均血液需求量随平均血红蛋白浓度逐渐上升,可能呈非线性方式。红细胞同种免疫的患病率随输血开始延迟而上升。17%的患者报告了1%的输血反应(其中90%为白细胞去除的输血)。